NEOG Stock: Price, Earnings History and SEC Filings
Neogen Corporation (NEOG) last traded at $11.82, down 3.59% on the latest session and down 7.7% over the past month. In its most recent reported quarter (Aug 2026) earnings per share were $0.07 against an analyst estimate of $0.04, a beat of 75.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NEOG earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Aug 2026 | Oct 6, 2026 | $0.07 | $0.04 | +75.00% |
| May 2026 | Jul 30, 2026 | $0.08 | $0.03 | +166.67% |
| Feb 2026 | Apr 9, 2026 | $0.08 | $0.02 | +300.00% |
| Nov 2025 | Jan 8, 2026 | $0.08 | $0.05 | +60.00% |
NEOG beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How NEOG reacts to earnings
Across its last 8 earnings releases, NEOG moved 15.1% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-06 | After close | -2.34% |
| 2026-07-30 | Before open | +22.66% |
| 2026-04-09 | Before open | -2.90% |
| 2026-01-08 | Before open | +31.57% |
| 2025-10-09 | Before open | +16.49% |
| 2025-07-29 | Before open | -10.89% |
| 2025-04-09 | Before open | -28.69% |
| 2025-01-10 | Before open | -5.43% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
NEOG financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $870M | -$8M | – | -0.9% | $-0.04 |
| 2025 | $895M | -$1.1B | – | -122.1% | $-5.03 |
| 2024 | $924M | -$9M | – | -1.0% | $-0.04 |
| 2023 | $822M | -$23M | – | -2.8% | $-0.12 |
| 2022 | $527M | $48M | – | 9.2% | $0.45 |
| 2021 | $468M | $61M | – | 13.0% | $0.57 |
| 2020 | $418M | $59M | – | 14.2% | $0.56 |
| 2019 | $414M | $60M | – | 14.5% | $0.57 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for NEOG
- 10-Q · Oct 7, 2026
- 8-K · Oct 7, 2026Shareholder vote, Financial statements and exhibits
- 8-K · Oct 6, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Aug 21, 2026
- 8-K · Aug 7, 2026Officer or director change
- 10-K · Jul 30, 2026
- 8-K · Jul 30, 2026Results of operations, Financial statements and exhibits
- 8-K · Apr 20, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Apr 9, 2026
- 8-K · Apr 9, 2026Results of operations, Financial statements and exhibits
Insider filing activity
NEOG insiders filed 25 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
NEOG news
- IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings?Oct 30, 2026 · trefis.com
- 3 Reasons to sell NEOG and 1 stock to buy insteadOct 24, 2026 · finance.yahoo.com
- NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?Oct 20, 2026 · finance.yahoo.com
- NEOG Q3 Deep Dive: Commercial Execution, Innovation, and Operational Progress Shape OutlookOct 19, 2026 · finance.yahoo.com
About Neogen Corporation
Neogen Corporation (NEOG) is a US-listed public company on Nasdaq. The SEC classifies its business as In Vitro & In Vivo Diagnostic Substances. It is incorporated in MI. Its fiscal year ends in May.